"Aspen Clinical Research is a medical research company that is contracted to help with studies to research medication and devices for pharmaceutical organizations throughout the world."

During the past decade, Aspen Clinical Research conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 30 clinical trials were completed, i.e. on average, 103.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 13 clinical trials were completed. i.e. 144.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aspen Clinical Research" #1 sponsor was "Pfizer" with 8 trials, followed by "Sunovion" with 7 trials sponsored, "Shire" with 3 trials sponsored, "Supernus Pharmaceuticals, Inc." with 3 trials sponsored and "AEON Biopharma, Inc." with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aspen Clinical Research" #1 collaborator was "Biogen" with 2 trials as a collaborator, "Cardiokine Biopharma, LLC" with 2 trials as a collaborator, "PPD" with 2 trials as a collaborator, "Aspen Clinical Research" with 1 trials as a collaborator and "Camurus AB" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Aspen Clinical Research" are "Attention Deficit Hyperactivity Disorder" (4 trials), "Chronic Pain" (4 trials), "Alzheimer's Disease" (3 trials), "Migraine" (3 trials) and "ADHD" (2 trials). Many other conditions were trialed in "Aspen Clinical Research" in a lesser frequency.

Most popular intervention types in "Aspen Clinical Research" are "Drug" (50 trials), "Other" (9 trials), "Biological" (3 trials), "Device" (2 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "ABP-450" (2 trials), "Hydrocodone ER" (2 trials), "Hydrocodone bitartrate q24h film-coated tablets" (2 trials) and "Lurasidone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Aspen Clinical Research" are 56 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Aspen Clinical Research". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 47 completed trials in Aspen Clinical Research, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Aspen Clinical Research, 8 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".